Current Ratio
since 2018
Calculation
Moderna Inc., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2023 | 3.42 | = | 10,325) | ÷ | 3,015) |
| Dec 31, 2022 | 2.73 | = | 13,431) | ÷ | 4,923) |
| Dec 31, 2021 | 1.76 | = | 16,071) | ÷ | 9,128) |
| Dec 31, 2020 | 1.43 | = | 6,298) | ÷ | 4,389) |
| Dec 31, 2019 | 7.89 | = | 1,129) | ÷ | 143) |
| Dec 31, 2018 | 7.02 | = | 1,563) | ÷ | 223) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 US$ in millions
Comparison to Competitors
Moderna Inc., current ratio, long-term trends, comparison to competitors
| Moderna Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 3.42 | 0.87 | 1.65 | 1.43 | 1.68 | 0.94 | 1.43 | 1.16 | 1.25 | 0.91 | 5.69 | 1.75 |
| Dec 31, 2022 | 2.73 | 0.96 | 1.41 | 1.25 | 1.89 | 1.05 | 1.29 | 0.99 | 1.47 | 1.22 | 5.06 | 1.48 |
| Dec 31, 2021 | 1.76 | 0.79 | 1.59 | 1.52 | 1.43 | 1.23 | 1.27 | 1.35 | 1.27 | 1.40 | 3.56 | 1.50 |
| Dec 31, 2020 | 1.43 | 0.84 | 1.81 | 1.58 | 1.86 | 1.40 | 1.40 | 1.21 | 1.02 | 1.35 | 3.63 | 2.13 |
| Dec 31, 2019 | 7.89 | 3.18 | 1.44 | 1.60 | 5.19 | 1.16 | 3.10 | 1.26 | 1.24 | 0.88 | 3.67 | 1.92 |
| Dec 31, 2018 | 7.02 | 0.98 | 2.79 | 1.61 | 1.47 | 1.73 | 3.38 | 1.47 | 1.17 | 1.57 | 4.47 | 1.73 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Moderna Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Moderna Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2023 | 3.42 | 1.26 |
| Dec 31, 2022 | 2.73 | 1.29 |
| Dec 31, 2021 | 1.76 | 1.35 |
| Dec 31, 2020 | 1.43 | 1.35 |
| Dec 31, 2019 | 7.89 | 1.66 |
| Dec 31, 2018 | 7.02 | 1.70 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Comparison to Industry (Health Care)
Moderna Inc., current ratio, long-term trends, comparison to industry (health care)
| Moderna Inc. | Health Care | |
|---|---|---|
| Dec 31, 2023 | 3.42 | 1.14 |
| Dec 31, 2022 | 2.73 | 1.16 |
| Dec 31, 2021 | 1.76 | 1.21 |
| Dec 31, 2020 | 1.43 | 1.21 |
| Dec 31, 2019 | 7.89 | 1.34 |
| Dec 31, 2018 | 7.02 | 1.38 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).